{"result": {"id": "ce074e38-17a6-4f11-a3ab-7ad5355f8a33", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>中华全科医师杂志<|>ORGANIZATION<|>A medical journal publishing research and guidelines on general practice medicine, including the 2025 May issue (Vol.24, No.5))  \n##  \n(\"entity\"<|>曲美布汀<|>PERSON<|>A prescription drug (Rx) used as an antispasmodic for gastrointestinal disorders)  \n##  \n(\"entity\"<|>匹维溴铵<|>PERSON<|>A prescription drug (Rx) used as an antispasmodic for gastrointestinal disorders)  \n##  \n(\"entity\"<|>蒙脱石散<|>PERSON<|>An over-the-counter (OTC) antidiarrheal medication)  \n##  \n(\"entity\"<|>盐酸洛哌丁胺<|>PERSON<|>A prescription drug (Rx) used to treat diarrhea by inhibiting intestinal motility)  \n##  \n(\"entity\"<|>地衣芽孢杆菌<|>PERSON<|>An OTC probiotic strain used to restore gut microbiota balance)  \n##  \n(\"entity\"<|>双歧杆菌三联活菌<|>PERSON<|>An OTC probiotic combination therapy for diarrhea and gut health)  \n##  \n(\"entity\"<|>枯草杆菌二联活菌<|>PERSON<|>An OTC probiotic preparation for intestinal dysbiosis)  \n##  \n(\"entity\"<|>酪酸梭菌活菌制剂<|>PERSON<|>An OTC probiotic treatment for diarrhea and immune restoration)  \n##  \n(\"entity\"<|>布拉酵母菌制剂<|>PERSON<|>An OTC probiotic supplement for managing diarrhea)  \n##  \n(\"entity\"<|>麦麸<|>PERSON<|>A dietary fiber source used as a bulk-forming laxative for constipation)  \n##  \n(\"entity\"<|>小麦纤维素<|>PERSON<|>A prescription (Rx) bulk-forming laxative)  \n##  \n(\"entity\"<|>聚卡波非钙<|>PERSON<|>A prescription (Rx) volume-increasing laxative)  \n##  \n(\"entity\"<|>聚乙二醇4000散<|>PERSON<|>An OTC osmotic laxative for constipation relief)  \n##  \n(\"entity\"<|>乳果糖口服溶液<|>PERSON<|>An OTC osmotic laxative for chronic constipation)  \n##  \n(\"entity\"<|>比沙可啶肠溶片<|>PERSON<|>An OTC stimulant laxative for short-term constipation treatment)  \n##  \n(\"entity\"<|>琥珀酸普芦卡必利片<|>PERSON<|>A prescription (Rx) prokinetic drug for adult women with constipation)  \n##  \n(\"entity\"<|>利那洛肽<|>PERSON<|>A prescription (Rx) secretagogue for chronic constipation)  \n##  \n(\"relationship\"<|>中华全科医师杂志<|>曲美布汀<|>The journal publishes guidelines mentioning the use of antispasmodics like Trimebutine<|>4)  \n##  \n(\"relationship\"<|>中华全科医师杂志<|>盐酸洛哌丁胺<|>The journal references Loperamide as a diarrhea treatment<|>4)  \n##  \n(\"relationship\"<|>盐酸洛哌丁胺<|>地衣芽孢杆菌<|>Both are treatments for diarrhea, with Loperamide reducing motility and probiotics restoring flora<|>3)  \n##  \n(\"relationship\"<|>双歧杆菌三联活菌<|>酪酸梭菌活菌制剂<|>Both are probiotic therapies for gut microbiota imbalance<|>5)  \n##  \n(\"relationship\"<|>聚乙二醇4000散<|>乳果糖口服溶液<|>Both are osmotic laxatives for constipation management<|>6)  \n##  \n(\"relationship\"<|>比沙可啶肠溶片<|>琥珀酸普芦卡必利片<|>Both treat constipation but via different mechanisms (stimulant vs. prokinetic)<|>4)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165401, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 910, "prompt_tokens": 2461, "total_tokens": 3371, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 669}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 痉药：曲美布汀(Rx) 、匹维溴铵(Rx) 等 。\n②止泻药：蒙脱石散(OTC)、盐酸洛哌丁胺\n\n\n\n\n中华全科医师杂志2025年5月第24卷第5期Chin J Gen Pract,May 2025,Vol.24,No.5                                                                       · 533 ·\n\n\n\n(Rx) 等。\n　　　　③益生菌：地衣芽孢杆菌(OTC)、双歧杆菌三 联活菌(OTC)、枯草杆菌二联活菌(OTC)、酪酸梭 菌活菌制剂(OTC)、布拉酵母菌制剂(OTC) 等。\n　　　　(4)用药注意事项：洛哌丁胺能抑制肠蠕动，减 少粪便量及水电解质流失，可以缩短腹泻病程。补 充益生菌，能够帮助恢复肠道菌群平衡，缩短腹泻 病程并恢复免疫力。益生菌的活菌制剂，应与抗菌 药物错开服药时间。\n3.便秘33]\n　　　　(1)主要症状：是指一种(组)临床症状，表现为 排便困难和/或排便次数减少、粪便干硬。排便困 难包括排便费力、排出困难、肛门直肠堵塞感、排便 不尽感、排便费时以及需辅助排便。排便次数减少 指每周排便<3次。\n　　　　(2)健康管理：合理膳食，增加膳食纤维摄入、多 饮水。便秘患者需要适当运动，尤其是长期卧床、运 动少的老人。建立良好的排便习惯，在晨起或餐后 2h  内尝试排便，排便时集中注意力，减少外界因素 的干扰，每次大便时间不宜过长(<10min/ 次)。\n(3)常用药物\n　　　　①容积性泻药：麦麸(食物)、小麦纤维素 (Rx) 、聚卡波非钙(Rx)  等 。\n　　　　②渗透性泻药：聚乙二醇4000散(OTC)、乳果 糖口服溶液(OTC) 等 。\n③刺激性泻药：比沙可啶肠溶片(OTC) 等。\n　　　　④促动力药：琥珀酸普芦卡必利片(Rx, 适 用 于成年女性)等。\n④促分泌药：利那洛肽(Rx)  等 。\n　　　　⑤益生菌/益生元：双歧杆菌、乳杆菌制剂 (OTC) 等。\n　　　　(4)用药注意事项：初次便秘时间超过2个月 建议医院就诊，需针对病因治疗。也可临时选用泻 药以缓解便秘症状，但应避免自行长时间使用刺激 性泻药(如蓖麻油、酚酞等);盐类渗透性泻药(如硫 酸镁等)可引起电解质紊乱，不应自行使用；容积性 泻药服用时应补充足量的液体。\n4.胃食管反流34]\n(1)主要症状：胃灼热、烧心、反酸。\n　　　　(2)健康管理：改变生活方式是治疗胃食管反\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_1545cbd3a4100531e1506dada21f225e51a6d43a8771abe0223bb79d04250805_v2"}